NCT03822897 2026-02-17EVADERCanadian Cancer Trials GroupPhase 2 Active not recruiting103 enrolled 11 charts
NCT02586207 2025-10-07Pembrolizumab in Combination With CRT for LA-SCCHNSanford HealthPhase 1 Completed59 enrolled 9 charts